Supplemental Figure 2 from Phase I/II Study of the Mesothelin-targeted Immunotoxin LMB-100 with Nab-Paclitaxel for Patients with Advanced Pancreatic Adenocarcinoma

Authors :: Ira Pastan
Raffit Hassan
William D. Figg
Jane B. Trepel
Seth M. Steinberg
Anish Thomas
Jessica D. Kindrick
Akira Yuno
Min-Jung Lee
Zishuo I. Hu
Cody J. Peer
Mehwish Ahmad
Christine Alewine
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Adverse events attributed to nab-paclitaxel

Tools